| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Carlson Capital, L.P. | 10%+ Owner | $4.2M | Aug 15, 2023 | ||
| Malcolm Fairbairn | Director | $520K | May 19, 2021 | ||
| Harlan F. Weisman | President and CEO, Director | $347K | Jul 3, 2024 | ||
| Zamaneh Mikhak | Chief Medical Officer | $61K | Jul 3, 2024 | ||
| Robert S. Mills | Director | $25K | Jul 3, 2024 | ||
| Kirk Allen Coleman | Chief Financial Officer | $22.1K | Jul 3, 2024 | ||
| Stephen Rocamboli | Director | $17.2K | Jul 3, 2024 | ||
| Glenn R. Mattes | President and CEO, Director | $16.8K | May 16, 2022 | ||
| Brandi Roberts | Director | $11.2K | Jul 3, 2024 | ||
| Catherine C. Lee | Director | $2.01K | Jul 3, 2024 | ||
| Thomas B. King | Director | $1.84K | Jul 3, 2024 | ||
| Michael Patane | Director | $1.39K | Apr 18, 2024 | ||
| Christopher Cano | Chief Operating Officer | Sep 22, 2021 | |||
| Randy H. Thurman | Director | Sep 29, 2022 | |||
| Aaron G.L. Fletcher | Director | Dec 29, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|